Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Lipocine Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 18 | 17 | −1 |
| Shares | 544.5K | 486.7K | −57.9K (−10.6%) |
| Value | $2.44M | $2.38M | −$69.9K (−2.9%) |
New holders (1)
Institutions that held Lipocine Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 65 | $317 | 0.00% |
Sold out (2)
Institutions that held Lipocine Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Clearstead Advisors, LLC | 74 | $333 |
| Tidemark, LLC | 59 | $265 |